Nørgaard-Pedersen B - Search Results

1

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Nørgaard-Pedersen B, Høgdall CK. Høgdall EV, et al. Cancer. 2003 Jul 1;98(1):66-73. doi: 10.1002/cncr.11476. Cancer. 2003. PMID: 12833457 Free article.

2

The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer.

Høgdall CK, Nørgaard-Pedersen B, Mogensen O. Høgdall CK, et al. Anticancer Res. 2002 May-Jun;22(3):1765-8. Anticancer Res. 2002. PMID: 12168866

3

Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients.

Høgdall EV, Høgdall CK, Christensen L, Glud E, Blaakaer J, Bock JE, Vuust J, Nørgaard-Pedersen B, Kjaer SK. Høgdall EV, et al. Anticancer Res. 2002 May-Jun;22(3):1859-64. Anticancer Res. 2002. PMID: 12168882

4

P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis.

Høgdall EV, Høgdall CK, Blaakaer J, Heegaard NH, Glud E, Christensen L, Bock JE, Nørgaard-Pedersen B, Wiik A, Kjaer SK. Høgdall EV, et al. APMIS. 2002 Aug;110(7-8):545-53. doi: 10.1034/j.1600-0463.2002.11007805.x. APMIS. 2002. PMID: 12390412

5

Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.

Høgdall EV, Kjaer SK, Glud E, Christensen L, Blaakaer J, Vuust J, Bock JE, Norgaard-Pedersen B, Hogdall CK. Høgdall EV, et al. Anticancer Res. 2003 Jul-Aug;23(4):3397-404. Anticancer Res. 2003. PMID: 12926080

6

Cancer-associated serum antigen level: a novel prognostic indicator for survival in patients with recurrent ovarian carcinoma.

Gronlund B, Dehn H, Høgdall CK, Engelholm SA, Jørgensen M, Nørgaard-Pedersen B, Høgdall EV. Gronlund B, et al. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):836-43. doi: 10.1111/j.1525-1438.2005.00145.x. Int J Gynecol Cancer. 2005. PMID: 16174233 Free article.

7

Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA.

Høgdall CK, Christensen IJ, Stephens RW, Sørensen S, Nørgaard-Pedersen B, Nielsen HJ. Høgdall CK, et al. APMIS. 2002 Sep;110(9):630-8. doi: 10.1034/j.1600-0463.2002.1100906.x. APMIS. 2002. PMID: 12529016

8

Plasma tetranectin and ovarian neoplasms.

Høgdall CK, Høgdall EV, Hørding U, Daugaard S, Clemmensen I, Nørgaard-Pedersen B, Toftager-Larsen K. Høgdall CK, et al. Gynecol Oncol. 1991 Nov;43(2):103-7. doi: 10.1016/0090-8258(91)90053-8. Gynecol Oncol. 1991. PMID: 1743549

9

Serum tetranectin and CA-125 used to monitor the course of treatment in ovarian cancer patients.

Høgdall CK, Hørding U, Nørgaard-Pedersen B, Toftager-Larsen K, Clemmensen I. Høgdall CK, et al. Eur J Obstet Gynecol Reprod Biol. 1994 Dec;57(3):175-8. doi: 10.1016/0028-2243(94)90296-8. Eur J Obstet Gynecol Reprod Biol. 1994. PMID: 7713292

10

Prognostic value of serum tetranectin in patients with metastatic breast cancer.

Høgdall CK, Sölétormos G, Nielsen D, Nørgaard-Pedersen B, Dombernowsky P, Clemmensen I. Høgdall CK, et al. Acta Oncol. 1993;32(6):631-6. doi: 10.3109/02841869309092443. Acta Oncol. 1993. PMID: 8260181 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters